EirGenix operates cGMP biologics manufacturing facilities in Xizhi and Zhubei, supporting preclinical and pilot-scale activities through late-stage clinical and commercial production. Both facilities offer mammalian cell culture and microbial fermentation capabilities. Mammalian manufacturing includes 200 L-2,000 L single-use bioreactors supported by purification, media and buffer preparation, and sterilization facilities. Microbial fermentation systems span 20 L-1,500 L across the two sites, supporting flexible production of biologics.